Clinical Takeaway In this randomized controlled trial, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation in healthy adults,...
`Cannabinoid Clinical Trials: CBD and Cortical Excitability`
Clinical Takeaway In a controlled trial of healthy males, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation compared...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this randomized controlled trial, neither a low nor high single dose of CBD directly altered cortical excitability or produced measurable sedation in healthy adults. These findings suggest that CBD's...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this randomized controlled trial, CBD at both low (30 mg) and high (700 mg) single doses failed to directly reduce cortical excitability in healthy adults, suggesting its anti-seizure effects...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial of 25 healthy males, neither low-dose (30 mg) nor high-dose (700 mg) CBD produced measurable changes in cortical excitability compared to placebo. These...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this randomized controlled trial, CBD at both low and high doses failed to directly reduce cortical excitability in healthy adults, suggesting its anti-seizure effects may depend more on interactions...
`Cannabinoid Clinical Trials: CBD Cortical Excitability Study`
Clinical Takeaway In this randomized, placebo-controlled crossover trial, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability or sedation in healthy adults, suggesting CBD alone...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high doses did not directly reduce cortical excitability compared to placebo, suggesting its anti-seizure benefits may depend...
endocannabinoid system: CBD & Cortical Excitability Trial
Clinical Takeaway In this randomized controlled trial, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation in healthy volunteers,...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this controlled trial of healthy adults, neither a low nor a high single dose of CBD directly altered cortical excitability compared to placebo, suggesting CBD may not have meaningful...